Carr Financial Group Corp »

Vertex Pharmaceuticals Incorporated shares owned by Carr Financial Group Corp

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Carr Financial Group Corp from 13F filings

Historical chart of Carr Financial Group Corp investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Carr Financial Group Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Carr Financial Group Corp

Quarter filed Position value Share count Share price at filing
2026-06-30 $207k 417 496.73
2025-06-30 $235k 528 445.20
2025-03-31 $295k 608 484.82

More positions owned by Carr Financial Group Corp

Vanguard Total Bond Market Etf Etf (BND)
Vanguard Dividend Appreciation Etf Etf (VIG)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Ishares Msci Intl Quality Factor Etf Etf (IQLT)
Jpmorgan Hedged Equity Laddered Overlay Etf Etf (HELO)
Vanguard Morningstar Total Stock Market Etf Etf (VTI)
Ishares 0-5 Year High Yield Corporate Bond Etf Etf (SHYG)
Ishares Msci Usa Quality Garp Etf Etf (GARP)
Invesco Qqq Trust Series I Etf (QQQ)
Ishares Core S&p Mid-cap Etf Etf (IJH)
Jpmorgan Nasdaq Equity Premium Income Etf Etf (JEPQ)
Avantis U.s. Small Cap Value Etf Etf (AVUV)
Ishares Core Dividend Growth Etf Etf (DGRO)
Spdr Gold Shares Etf (GLD)
Vanguard Morningstar Small-cap Etf Etf (VB)

View all positions for Carr Financial Group Corp

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Invesco
Jpmorgan Chase & Co
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Franklin Resources
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated